• Family of patient who died after orthopedic surgery wins $35M verdict against hospital
  • Orthopedic surgeon wins $20M verdict against Johnson & Johnson
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon's video hits 1 million views on TikTok
  • Spine surgeon killed in Oklahoma hospital shooting
  • Spine surgeon owes $17M to paralyzed patient
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • 23 spine device companies to watch in 2022
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon salary vs. average household income in each state
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Orthopedic surgeon convicted of battery at hospital
  • Billionaire spine surgeon buys $23.9M mansion
  • UArizona neurosurgery chair dies after motorcycle collision
  • The spine tech surgeons say will explode in the next 5 years
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • Could Medtronic's spine business be the next medtech spinoff?
  • Ex-NFL player gets 5 years in prison for $2.9M healthcare fraud scheme
  • 41 'rising stars' in orthopedics
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon fined for operating on wrong knee
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Lawsuits build against Aetna's spine surgery coverage
  • Former spine surgeon owes $13M to 2 women over unnecessary procedures
  • Walmart's latest partnership pushes retailer into spine care
  • Texas spine surgeon's $11M verdict being appealed
  • 10 power players in orthopedics
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon allegedly exaggerated patient visits to defraud insurers
  • Top orthopedic hospital in every state: US News
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • Medtronic sees Q2 growth in neurosurgery: 5 notes

    Medtronic sees Q2 growth in neurosurgery: 5 notes

    Marcus Robertson -  

    Medtronic's cranial and spine technologies division saw a slight revenue decrease in the second quarter of the 2022 fiscal year, and the company earned $7.84 billion in total revenue.

    The financial results were posted Nov. 23.

    Five things to know:

    1. Cranial and spinal technology business saw revenue of $1.07 billion, down 1 percent compared to the same period last year. 

    2. Spine and biologics decreased at a mid-single-digit percentage, and neurosurgery grew at a high single-digit percentage year over year. The company noted continued strong sales for Medtronic's surgical robots including Midas Rex, StealthStation and O-arm imaging. 

    3. U.S. revenue was nearly $4 billion, a 1 percent decrease year over year. Non-U.S. revenue was $2.48 billion, a 1 percent increase year over year.

    4. Medtronic's neuromodulation business revenue grew 6 percent to $435 million. Brain modulation grew at a mid-20s percentage, driven by the launch of the Percept PC and SenSight deep brain stimulation systems. Pain therapy business decreased at a mid-single-digit percentage.

    5. Medtronic adjusted its earnings guidance and expects a 7 percent to 8 percent increase in total revenue in fiscal 2022. It previously projected a 9 percent increase.

    "Our second quarter results reflect focused execution of our strategy and the strong underlying health of the business, despite the market impact of the pandemic resurgence and healthcare system staffing challenges on medical procedure volumes, particularly in the U.S., which affected our quarterly revenue growth," CEO Geoff Martha said.

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Learning Opportunities

    Featured Webinars

    Featured Podcast

    Featured Whitepapers